Page last updated: 2024-08-24

plerixafor and Abnormalities, Autosome

plerixafor has been researched along with Abnormalities, Autosome in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Azab, AK; Chatterjee, M; Decker, S; Duyster, J; Engelhardt, M; Follo, M; Ihorst, G; Lorenz, J; Müller, SJ; Simon, A; Waldschmidt, JM; Wäsch, R; Wider, D1

Other Studies

1 other study(ies) available for plerixafor and Abnormalities, Autosome

ArticleYear
CXCL12 and CXCR7 are relevant targets to reverse cell adhesion-mediated drug resistance in multiple myeloma.
    British journal of haematology, 2017, Volume: 179, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Aptamers, Nucleotide; Benzylamines; Biomarkers; Bone Marrow Cells; Cell Adhesion; Cell Line, Tumor; Chemokine CXCL12; Chromosome Aberrations; Coculture Techniques; Cyclams; Drug Resistance, Neoplasm; Female; Gene Expression Regulation, Neoplastic; Heterocyclic Compounds; Humans; Immunophenotyping; Male; Middle Aged; Mitogen-Activated Protein Kinase 1; Multiple Myeloma; Neoplasm Staging; Oligopeptides; Phosphorylation; Protein Multimerization; Protein Transport; Receptors, CXCR; Stromal Cells

2017